[go: up one dir, main page]

HUP0300689A3 - Method and compositions for treating an inflammatory disease - Google Patents

Method and compositions for treating an inflammatory disease

Info

Publication number
HUP0300689A3
HUP0300689A3 HU0300689A HUP0300689A HUP0300689A3 HU P0300689 A3 HUP0300689 A3 HU P0300689A3 HU 0300689 A HU0300689 A HU 0300689A HU P0300689 A HUP0300689 A HU P0300689A HU P0300689 A3 HUP0300689 A3 HU P0300689A3
Authority
HU
Hungary
Prior art keywords
compositions
treating
inflammatory disease
inflammatory
disease
Prior art date
Application number
HU0300689A
Other languages
Hungarian (hu)
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of HUP0300689A2 publication Critical patent/HUP0300689A2/en
Publication of HUP0300689A3 publication Critical patent/HUP0300689A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HU0300689A 2000-02-08 2001-02-08 Method and compositions for treating an inflammatory disease HUP0300689A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18087900P 2000-02-08 2000-02-08
PCT/US2001/003972 WO2001058441A1 (en) 2000-02-08 2001-02-08 Method and compositions for treating an inflammatory disease

Publications (2)

Publication Number Publication Date
HUP0300689A2 HUP0300689A2 (en) 2003-07-28
HUP0300689A3 true HUP0300689A3 (en) 2003-09-29

Family

ID=22662062

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0300689A HUP0300689A3 (en) 2000-02-08 2001-02-08 Method and compositions for treating an inflammatory disease

Country Status (16)

Country Link
EP (1) EP1253919A4 (en)
JP (1) JP2003522142A (en)
KR (1) KR20020073577A (en)
CN (1) CN1398181A (en)
AU (1) AU7205701A (en)
BR (1) BR0108087A (en)
CA (1) CA2398184A1 (en)
CZ (1) CZ20022682A3 (en)
HK (1) HK1051319A1 (en)
HU (1) HUP0300689A3 (en)
IL (1) IL150963A0 (en)
MX (1) MXPA02007688A (en)
NO (1) NO20023737L (en)
PL (1) PL356447A1 (en)
WO (1) WO2001058441A1 (en)
ZA (1) ZA200206252B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7338971B2 (en) * 2001-08-30 2008-03-04 El-Naggar Mawaheb M Treatment of inflammatory, cancer, and thrombosis disorders
CA2459757C (en) * 2001-09-19 2011-08-30 Altana Pharma Ag Combination
JP2005515975A (en) * 2001-10-31 2005-06-02 メルク　パテント　ゲゼルシャフト　ミット　ベシュレンクテル　ハフトング Type 4 phosphodiesterase inhibitors and uses thereof
WO2004098605A1 (en) * 2003-05-12 2004-11-18 Altana Pharma Ag Pharmaceutical composition comprising a pde4 inhibitor and il-1 trap
WO2005020926A2 (en) * 2003-08-28 2005-03-10 Pharmacia Corporation Treatment or prevention of vascular disorders with cox-2 inhibitors in combination with cyclic amp-specific phosphodiesterase inhibitors
JP2012519160A (en) * 2009-02-27 2012-08-23 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Combination drug containing PDE4 inhibitor and NSAID
WO2010097332A1 (en) * 2009-02-27 2010-09-02 Boehringer Ingelheim International Gmbh Drug combinations containing pde4 inhibitors and nsaids
PT2593452T (en) 2010-07-14 2017-04-24 Novartis Ag HETEROCYCLICAL COMPOUNDS OF THE IP RECEIVER
CN104053659B (en) 2012-01-13 2016-11-09 诺华股份有限公司 Fused azoles as IP receptor agonists for the treatment of pulmonary arterial hypertension (PAH) and related disorders
WO2014125413A1 (en) 2013-02-13 2014-08-21 Novartis Ag Ip receptor agonist heterocyclic compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4061779A (en) * 1973-09-11 1977-12-06 Beecham Group Limited Naphthalene derivatives having anti-inflammatory activity
GB9108128D0 (en) * 1991-04-15 1991-06-05 Zambeletti Spa L Novel formulation
US5552438A (en) * 1992-04-02 1996-09-03 Smithkline Beecham Corporation Compounds useful for treating allergic and inflammatory diseases
US6005118A (en) * 1996-05-03 1999-12-21 Caron; Stephane Methods of preparing 4-cyano-4 (substituted indazole) cyclohexane-carboxylic acids useful as PDE4 inhibitors
FR2753706B1 (en) * 1996-09-20 1998-10-30 NOVEL N-SUBSTITUTED CYCLIC AMINES, THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Also Published As

Publication number Publication date
NO20023737D0 (en) 2002-08-07
BR0108087A (en) 2002-10-29
HUP0300689A2 (en) 2003-07-28
IL150963A0 (en) 2003-02-12
AU7205701A (en) 2001-08-20
JP2003522142A (en) 2003-07-22
HK1051319A1 (en) 2003-08-01
CN1398181A (en) 2003-02-19
CA2398184A1 (en) 2001-08-16
EP1253919A4 (en) 2007-03-14
KR20020073577A (en) 2002-09-27
NO20023737L (en) 2002-09-27
CZ20022682A3 (en) 2003-09-17
PL356447A1 (en) 2004-06-28
MXPA02007688A (en) 2002-12-13
EP1253919A1 (en) 2002-11-06
ZA200206252B (en) 2003-08-26
WO2001058441A1 (en) 2001-08-16

Similar Documents

Publication Publication Date Title
AP2006003708A0 (en) Methods and compositions for treating flavivirusesand pestiviruses
IL144517A0 (en) Compositions and methods for treating cataracts
AU2001245437A1 (en) Lightweight methods and compositions for well treating
AU2002219945A1 (en) Composition and method for treating snoring
AU2001288271A1 (en) Methods for treating inflammatory diseases
AU6832101A (en) Composition and method
AU5294100A (en) Method and compositions for treating the inflammatory response
AU4163402A (en) Composition and method
HUP0200224A3 (en) Compositions for treating inflammatory response
SG101494A1 (en) Exposure method
EP1351647A4 (en) Compositions and methods for treating hyperpigmentation
EP1512415A4 (en) Decoy composition for treating and preventing inflammatory disease
EP1461047A4 (en) Compositions and methods for animal treatment
HUP0300689A3 (en) Method and compositions for treating an inflammatory disease
IL155174A0 (en) Methods and compositions for the treatment of inflammatory diseases
EP1450820A4 (en) Method for treating or preventing inflammatory diseases
IL149367A0 (en) Method and compositions for treating pulmonary diseases
AU4515001A (en) Compositions and methods for locally treating inflammatory diseases
IL155769A0 (en) Method for the treatment of inflammation
EP1444983A4 (en) Agents for treating inflammatory bowel diseases
EP1277270A4 (en) Commutator and method for manufacture
EP1349548A4 (en) Methods and compositions for treating periodontal disease
GB0118883D0 (en) Method for treating objects
GB0123898D0 (en) Method for treating objects
AU2001238288A1 (en) Method and compositions for treating fibrotic diseases

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees